S&P 500: 681.75 +0.1% NASDAQ 100: 601.92 +0.2% Dow Jones: 495.28 +0.1%

Lee Ainslie’s LH Holdings & Trades

First Buy
Q3 2025
Duration Held
2 Quarters
Largest Add
Q3 2025
+10,149 Shares
Current Position
17,564 Shares
$4.41 M Value

Lee Ainslie's LH Position Overview

Lee Ainslie (via Maverick Capital LTD) currently holds 17,564 shares of Labcorp Holdings Inc. (LH) worth $4.41 M, representing 0.05% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.

Based on recent 13F filings, Lee Ainslie has initiated a new position in LH, representing a fresh investment thesis on this company. Largest addition occurred in Q4 2025, adding 7,415 shares.

Analysis based on 13F filings available since 2013 Q2

Lee Ainslie's Labcorp Holdings (LH) Holding Value Over Time

Track share changes against reported price movement

Quarterly Labcorp Holdings (LH) Trades by Lee Ainslie

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2025 +10,149 New Buy 10,149 $287.06
Q4 2025 +7,415 Add 73.06% 17,564 $250.88

Lee Ainslie's Labcorp Holdings Investment FAQs

Lee Ainslie first purchased Labcorp Holdings Inc. (LH) in Q3 2025, acquiring 10,149 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Lee Ainslie has held Labcorp Holdings Inc. (LH) for 2 quarters since Q3 2025.

Lee Ainslie's largest addition to Labcorp Holdings Inc. (LH) was in Q3 2025, adding 10,149 shares worth $2.91 M.

According to the latest 13F filing for Q4 2025, Lee Ainslie's firm, Maverick Capital LTD, owns 17,564 shares of Labcorp Holdings Inc. (LH), valued at approximately $4.41 M.

As of the Q4 2025 filing, Labcorp Holdings Inc. (LH) represents approximately 0.05% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.

Lee Ainslie's peak holding in Labcorp Holdings Inc. (LH) was 17,564 shares, as reported at the end of Q4 2025.